Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
Vigneau, Cécile
Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure. [electronic resource] - Journal of nephrology - 684-9 p. digital
Publication Type: Comparative Study; Journal Article
1121-8428
Adult
Aged
Cohort Studies
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Maximum Tolerated Dose
Melphalan--administration & dosage
Middle Aged
Multiple Myeloma--complications
Pilot Projects
Probability
Prognosis
Prospective Studies
Renal Insufficiency--complications
Risk Assessment
Severity of Illness Index
Survival Analysis
Treatment Outcome
Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure. [electronic resource] - Journal of nephrology - 684-9 p. digital
Publication Type: Comparative Study; Journal Article
1121-8428
Adult
Aged
Cohort Studies
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Maximum Tolerated Dose
Melphalan--administration & dosage
Middle Aged
Multiple Myeloma--complications
Pilot Projects
Probability
Prognosis
Prospective Studies
Renal Insufficiency--complications
Risk Assessment
Severity of Illness Index
Survival Analysis
Treatment Outcome